Shares of Abbott, which makes the Similac formula, rose 5.4% to $119.50 in after-hours trading Thursday. The stock ended the regular session having edged lower by 0.9% to $113.37, and is up 3% ...
The trial, which lasted more than a month, was the first time jurors weighed allegations about both Abbott’s Similac formula and Reckitt’s Enfamil in a single case. The hospital where ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback